Fiche centre
Brussels — centre non communiqué
Brussels — Belgium
Essais liés2clinical trials
VilleBrusselslocalisation
PaysBelgiumlocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT02257736
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Apalutamide | Cancer | Phase 3 | NCT02257736 | An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) | ACTIVE_NOT_RECRUITING |
| Lasmiditan | Migraine | Phase 2 | NCT00883051 | Dose-ranging Study of Oral COL-144 in Acute Migraine Treatment | COMPLETED |